James P. Perras

1.3k total citations
48 papers, 1.1k citations indexed

About

James P. Perras is a scholar working on Molecular Biology, Oncology and Reproductive Medicine. According to data from OpenAlex, James P. Perras has authored 48 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 18 papers in Oncology and 9 papers in Reproductive Medicine. Recurrent topics in James P. Perras's work include Cancer therapeutics and mechanisms (9 papers), Ovarian cancer diagnosis and treatment (9 papers) and Cancer Genomics and Diagnostics (6 papers). James P. Perras is often cited by papers focused on Cancer therapeutics and mechanisms (9 papers), Ovarian cancer diagnosis and treatment (9 papers) and Cancer Genomics and Diagnostics (6 papers). James P. Perras collaborates with scholars based in United States, Germany and Switzerland. James P. Perras's co-authors include Edward J. Kuenzler, Bernd‐Uwe Sevin, Hervy E. Averette, Manuel Peñalver, Ossi R. Koechli, Roberto Angioli, Albert Steren, Hervy E. Averette, Bernd‐Uwe Sevin and Daniel Donato and has published in prestigious journals such as Cancer, Limnology and Oceanography and American Journal of Obstetrics and Gynecology.

In The Last Decade

James P. Perras

48 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
James P. Perras United States 18 395 363 171 142 133 48 1.1k
Elena Riccardi Italy 19 99 0.3× 402 1.1× 169 1.0× 109 0.8× 112 0.8× 32 953
Yutaka Okumura Japan 21 163 0.4× 508 1.4× 160 0.9× 14 0.1× 137 1.0× 115 1.3k
Jaime Matta Puerto Rico 21 474 1.2× 760 2.1× 306 1.8× 46 0.3× 102 0.8× 62 1.9k
Francesco Esposito Italy 33 226 0.6× 1.6k 4.4× 309 1.8× 68 0.5× 219 1.6× 83 2.7k
Hiroshi Sasaki Japan 17 372 0.9× 440 1.2× 88 0.5× 434 3.1× 147 1.1× 48 1.4k
Gergana Metodieva United Kingdom 16 164 0.4× 421 1.2× 63 0.4× 27 0.2× 72 0.5× 23 774
Qian Hu China 19 159 0.4× 657 1.8× 46 0.3× 47 0.3× 65 0.5× 60 1.1k
Michele K. Montagna Italy 18 401 1.0× 478 1.3× 25 0.1× 120 0.8× 34 0.3× 25 1.3k
Frank J. Calzone United States 23 403 1.0× 1.6k 4.3× 111 0.6× 72 0.5× 242 1.8× 43 2.1k
Fanny Gaillard France 23 632 1.6× 256 0.7× 191 1.1× 10 0.1× 120 0.9× 50 1.8k

Countries citing papers authored by James P. Perras

Since Specialization
Citations

This map shows the geographic impact of James P. Perras's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James P. Perras with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James P. Perras more than expected).

Fields of papers citing papers by James P. Perras

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James P. Perras. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James P. Perras. The network helps show where James P. Perras may publish in the future.

Co-authorship network of co-authors of James P. Perras

This figure shows the co-authorship network connecting the top 25 collaborators of James P. Perras. A scholar is included among the top collaborators of James P. Perras based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James P. Perras. James P. Perras is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Janicek, Mike F., Bernd‐Uwe Sevin, James P. Perras, et al.. (1997). In VitroAntigene Therapy Targeting HPV-16 E6 and E7 in Cervical Carcinoma. Gynecologic Oncology. 64(1). 18–25. 31 indexed citations
2.
Rodriguez, Michael, Bernd‐Uwe Sevin, James P. Perras, et al.. (1995). Paclitaxel: A Radiation Sensitizer of Human Cervical Cancer Cells. Gynecologic Oncology. 57(2). 165–169. 45 indexed citations
3.
Petru, Edgar, et al.. (1995). A Correlation of Cell Cycle Perturbations with Chemosensitivity in Human Ovarian Cancer Cells Exposed to Cytotoxic Drugs in Vitro. Gynecologic Oncology. 58(1). 48–57. 8 indexed citations
4.
Sevin, Bernd‐Uwe, James P. Perras, & Ossi R. Köchli. (1994). Current Status and Future Directions of Chemosensitivity Testing. PubMed. 19. 179–194. 5 indexed citations
5.
Nguyen, Hoa N., Bernd‐Uwe Sevin, James P. Perras, & Hervy E. Averette. (1994). Review of Data on Gynecologic Cancer Cell Lines: Potential Applications of ATP-Cell Viability Assays. PubMed. 19. 132–144. 1 indexed citations
6.
Köchli, Ossi R., James P. Perras, & Bernd‐Uwe Sevin. (1994). ATP-Cell Viability Assay Methodology in Both Fresh Gynecologic Tumors and Cell Lines. PubMed. 19. 108–121. 4 indexed citations
7.
Koechli, Ossi R., Bernd‐Uwe Sevin, James P. Perras, et al.. (1994). Growth Characteristics of Nonmalignant Cells in the ATP Cell Viability Assay. Oncology. 51(1). 35–41. 9 indexed citations
8.
Untch, Michael, Bernd‐Uwe Sevin, James P. Perras, et al.. (1994). Evaluation of Paclitaxel (Taxol), Cisplatin, and the Combination Paclitaxel-Cisplatin in Ovarian Cancer in Vitro with the ATP Cell Viability Assay. Gynecologic Oncology. 53(1). 44–49. 23 indexed citations
9.
Lucas, F Anthony San, et al.. (1993). A novel model of a metastatic human breast tumour xenograft line. British Journal of Cancer. 68(2). 274–276. 36 indexed citations
10.
Nguyen, Hoa N., Bernd‐Uwe Sevin, Hervy E. Averette, et al.. (1993). Radiosensitization of Uterine Cancer Cell Lines by Cytotoxic Agents. Gynecologic Oncology. 48(1). 16–22. 9 indexed citations
11.
Koechli, Ossi R., Bernd‐Uwe Sevin, James P. Perras, et al.. (1993). Characteristics of the combination paclitaxel plus doxorubicin in breast cancer cell lines analyzed with the ATP-Cell Viability Assay. Breast Cancer Research and Treatment. 28(1). 21–27. 23 indexed citations
12.
Steren, Albert, Bernd‐Uwe Sevin, James P. Perras, et al.. (1993). Taxol Sensitizes Human Ovarian Cancer Cells to Radiation. Gynecologic Oncology. 48(2). 252–258. 81 indexed citations
13.
Nguyen, Hoa N., et al.. (1992). Spectrum of cell-cycle kinetics of alkylating agent Adolezesin in gynecological cancer cell lines: correlation with drug-induced cytotoxicity. Journal of Cancer Research and Clinical Oncology. 118(7). 515–522. 9 indexed citations
14.
Sevin, Bernd‐Uwe, et al.. (1992). In vitro evaluation of a novel chemotherapeutic agent, adozelesin, in gynecologic-cancer cell lines. Cancer Chemotherapy and Pharmacology. 30(1). 37–42. 7 indexed citations
15.
Untch, Michael, Bernd‐Uwe Sevin, James P. Perras, et al.. (1992). Chemosensitivity to the new anthracycline pirarubicin and other chemotherapeutic agents in primary and recurrent ovarian tumors in vitro. Gynecologic Oncology. 47(2). 172–178. 7 indexed citations
16.
Angioli, Roberto, Bernd‐Uwe Sevin, James P. Perras, et al.. (1992). Rationale of Combining Radiation and Interferon for the Treatment of Cervical Cancer. Oncology. 49(6). 445–449. 11 indexed citations
17.
Nguyen, Hoa N., Bernd‐Uwe Sevin, Hervy E. Averette, et al.. (1992). Determination of hormonal response in uterine cancer cell lines by the ATP bioluminescence assay and flow cytometry. Gynecologic Oncology. 46(1). 55–61. 9 indexed citations
18.
Gerhardt, Robert T., James P. Perras, Bernd‐Uwe Sevin, et al.. (1991). Characterization of in vitro chemosensitivity of perioperative human ovarian malignancies by adenosine triphosphate chemosensitivity assay. American Journal of Obstetrics and Gynecology. 165(2). 245–255. 14 indexed citations
19.
Nguyen, Hoa N., Bernd‐Uwe Sevin, Hervy E. Averette, et al.. (1991). Comparative evaluation of single and combination chemotherapy in uterine cancer cell lines. Gynecologic Oncology. 42(3). 227–232. 12 indexed citations
20.
Petru, Edgar, Bernd‐Uwe Sevin, Hervy E. Averette, et al.. (1990). Comparison of three tumor markers—CA-125, lipid-associated sialic acid (LSA), and —In monitoring ovarian cancer. Gynecologic Oncology. 38(2). 181–186. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Elena Riccardi Breakdown of academic impact, for papers by Yutaka Okumura Breakdown of academic impact, for papers by Jaime Matta Breakdown of academic impact, for papers by Francesco Esposito Breakdown of academic impact, for papers by Hiroshi Sasaki Breakdown of academic impact, for papers by Gergana Metodieva Breakdown of academic impact, for papers by Qian Hu Breakdown of academic impact, for papers by Michele K. Montagna Breakdown of academic impact, for papers by Frank J. Calzone Breakdown of academic impact, for papers by Fanny Gaillard
Rankless by CCL
2026